Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 9Active not recruiting 7Completed 3Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 36INDUSTRY 15NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 84Other hematologic neoplasm 73Lymphoid 73Genitourinary 65Dermatologic 64Thoracic 62Breast 50Sarcoma 48CNS 40Gynecologic 32Other solid neoplasm 29Head & Neck 27Plasma cell 18Myeloid 16Endocrine 16Tumor-Agnostic 8Other 3NET 2Classical hematology 2

Conditions

Neuroendocrine Tumors 2Carcinoma, Neuroendocrine 2Neoplasms 1

Interventions

Sunitinib 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NIH × NET × Clear all
NCT04488263 2023-01-17

Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

National Institutes of Health Clinical Center (CC)

Terminated
30 enrolled
EndocrineNET

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT02315625 2020-09-09

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
16 enrolled 15 charts
EndocrineNET

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡